Propedix is a pioneering biopharma and consumer health company committed to delivering innovative treatments at the forefront of healthcare. Our mission is to provide effective, science-backed solutions for patients affected by Athlete’s Foot and other fungal conditions. Our focus is at the nexus of 3 growth health segments.
We bring a robust lifecycle management approach to our OTC and Rx products, with a strong pipeline supported by comprehensive clinical studies and IP protections. This allows us to develop groundbreaking products that address real patient needs in dermatology and health.
Our flagship product, featuring our breakthrough anti-fungal and drying agent technology, is set to launch in Q1 2025. Backed by forward-thinking research and development, Propedix is dedicated to advancing next-generation health solutions for patients.
Meet the Team
A leading team of accomplished executives innovating in healthcare.
Dr. Carl Schanbacher
Founder, Chief Medical Officer
Dermatologist, South End Skin Care, Mass General Brigham/Martha's Vineyard Hospital Department of Surgery
M.D., University of Nebraska
Niv Caviar
Chief Operating Officer, Chief Financial Officer
Allergan, La Jolla Pharma, Suneva Medical, Affymetrix, Accenture, BiVacor
MBA, Harvard Business School
Carl Swedberg
Chief Commercial Officer
Pfizer, Weight Watchers
M.A. Marketing, Thunderbird
Dr. Nick Manesis
Chief Technology Officer
Allergan, CooperVision, Ocular Sciences, Revision Optics, Hewlett-Packard Co.
PhD, Chemistry, UC-San Diego
Dr. David Osborne
R&D, Formulation Advisor
Arcutis, Tolmar, Artix Labs
Ph.D., Univ of Missouri (MS&T)
Lisa Koch-Hulle
Clinical Ops, Regulatory Advisor
Alliance Pharma, La Jolla Pharma, Light Sciences Oncology
B.S., SDSU